Zdrowie i gospodarka · 25/07/2011
Office of Biotechnology Activities Updates NIH Guidelines for Recombinant DNA Research
The Office of Biotechnology Activities is revising its guidelines for research involving recombinant DNA molecules, aiming to enhance safety and oversight in the field.
Source: Federal Register — Health and Human ServicesOpen original release →